Developing a sustainable biosimilar marketplace

ISPOR 2020 Does short-term gain lead to longer term pain? The case for developing a sustainable biosimilar marketplace


Biosimilars offer the potential for €2 billion of savings annually across the EU. To facilitate biosimilar uptake, several mechanisms aimed at reducing the acquisition cost of biosimilars and encouraging biosimilar uptake have been implemented. However, the mechanisms used vary across the EU and it is unclear which mechanisms contribute towards a sustainable biosimilar marketplace. Using publicly available information combined with stakeholder interviews across the EU5, a number of mechanisms were identified and assessed towards biosimilar sustainability.

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.